Published in Clin Exp Immunol on May 01, 1989
Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med (1992) 10.08
Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (1992) 7.74
Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice. Infect Immun (1995) 3.31
Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev (1996) 2.55
Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot. Proc Natl Acad Sci U S A (1990) 2.46
Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components. J Clin Invest (1993) 2.38
Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor. Infect Immun (1992) 2.33
Expression of the Mycobacterium tuberculosis 19-kilodalton antigen in Mycobacterium smegmatis: immunological analysis and evidence of glycosylation. Infect Immun (1993) 2.12
Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J Clin Invest (1995) 1.85
Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat. J Clin Invest (1995) 1.68
Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients. J Exp Med (1992) 1.63
Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. Thorax (1996) 1.61
Tumor necrosis factor production in patients with leprosy. Infect Immun (1992) 1.55
Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection? PLoS Negl Trop Dis (2011) 1.51
Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-kappa B. Proc Natl Acad Sci U S A (1994) 1.50
Mycobacterial 65-kD heat shock protein induces release of proinflammatory cytokines from human monocytic cells. Clin Exp Immunol (1993) 1.43
Induction of inducible nitric oxide synthase-NO* by lipoarabinomannan of Mycobacterium tuberculosis is mediated by MEK1-ERK, MKK7-JNK, and NF-kappaB signaling pathways. Infect Immun (2001) 1.42
Selective induction of transforming growth factor beta in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Infect Immun (1996) 1.39
Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes. Infect Immun (1994) 1.39
Effect of mycobacteria on sensitivity to the cytotoxic effects of tumor necrosis factor. Infect Immun (1991) 1.31
Regulation of the interleukin-1 beta (IL-1 beta) gene by mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL6 motifs. Mol Cell Biol (1993) 1.28
A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab') fragment prolong survival of mice infected with Mycobacterium tuberculosis. Clin Exp Immunol (2004) 1.25
Two soluble antigens of Plasmodium falciparum induce tumor necrosis factor release from macrophages. Infect Immun (1990) 1.21
Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence. Infect Immun (1993) 1.16
The effect of Mycobacterium tuberculosis on the susceptibility of human cells to the stimulatory and toxic effects of tumour necrosis factor. Immunology (1992) 1.16
Production of tumor necrosis factors alpha and beta by human mononuclear leukocytes stimulated with mitogens, bacteria, and malarial parasites. Infect Immun (1990) 1.14
Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein. Gut (1990) 1.14
Lipoarabinomannans derived from different strains of Mycobacterium tuberculosis differentially stimulate the activation of NF-kappa B and KBF1 in murine macrophages. Infect Immun (1995) 1.14
Immunoglobulin G subclass responses to mycobacterial lipoarabinomannan in HIV-infected and non-infected patients with tuberculosis. Clin Exp Immunol (1993) 1.12
Prominent role for T cell-derived tumour necrosis factor for sustained control of Mycobacterium tuberculosis infection. Sci Rep (2013) 1.10
In vitro production of tumour necrosis factor and prostaglandin E2 by peripheral blood mononuclear cells from tuberculosis patients. Clin Exp Immunol (1990) 1.01
Role of the NF-kappaB signaling pathway and kappaB cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide. Infect Immun (2003) 1.00
Specific inhibition of mRNA accumulation for lymphokines in human T cell line Jurkat by mycobacterial lipoarabinomannan antigen. Clin Exp Immunol (1992) 0.98
A model for the investigation of factors influencing haemorrhagic necrosis mediated by tumour necrosis factor in tissue sites primed with mycobacterial antigen preparations. Clin Exp Immunol (1992) 0.95
Effect of lipoarabinomannan and mycobacteria on tumour necrosis factor production by different populations of murine macrophages. Clin Exp Immunol (1993) 0.94
Identification by two-dimensional gel electrophoresis of a 58-kilodalton tumor necrosis factor-inducing protein of Mycobacterium tuberculosis. Infect Immun (1993) 0.93
Comparative effects of Mycobacterium avium glycopeptidolipid and lipopeptide fragment on the function and ultrastructure of mononuclear cells. Clin Exp Immunol (1993) 0.91
An Afghan child with deep vein thrombosis. J R Soc Med (2003) 0.90
Divergent effects of mycobacterial cell wall glycolipids on maturation and function of human monocyte-derived dendritic cells. PLoS One (2012) 0.89
Life-threatening disseminated tuberculosis as a complication of TNF-α blockade in an adolescent. Eur J Pediatr (2011) 0.86
Inositol monophosphate phosphatase genes of Mycobacterium tuberculosis. BMC Microbiol (2010) 0.84
Cytokine induction in human coccidioidomycosis. Infect Immun (1994) 0.84
Mycobacterial lipoarabinomannan induces nitric oxide and tumor necrosis factor alpha production in a macrophage cell line: down regulation by taurine chloramine. Infect Immun (1994) 0.83
Analysis of Toll-like receptors, iNOS and cytokine profiles in patients with pulmonary tuberculosis during anti-tuberculosis treatment. PLoS One (2014) 0.81
Altered expression of CD11/CD18 on the peripheral blood phagocytes of patients with tuberculosis. Clin Exp Immunol (1994) 0.80
Striking the right balance; the role of cytokines in mycobacterial disease. Clin Exp Immunol (1993) 0.80
Tumour Necrosis Factor-alpha Production and Immune Cell Activation in Tuberculous Meningitis. Mediators Inflamm (1994) 0.78
Mycobacteria counteract a TLR-mediated nitrosative defense mechanism in a zebrafish infection model. PLoS One (2014) 0.78
Effect of mycobacterial phospholipids on interaction of Mycobacterium tuberculosis with macrophages. Infect Immun (2001) 0.78
Dexamethasone intravitreal implants in the management of tubercular multifocal serpiginoid choroiditis. J Ophthalmic Inflamm Infect (2016) 0.75
[Spinal tuberculosis complicated by acute ischemia of the lower limbs--report of a case]. Pan Afr Med J (2011) 0.75
Splenic Vein Thrombosis as a Rare Complication of Disseminated Tuberculosis - Imaging Diagnosis and Case Report. Pol J Radiol (2017) 0.75
An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A (1975) 23.42
Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature (1986) 11.09
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med (1986) 10.91
Studies of enterobacterial lipopolysaccharides; effects of heat and chemicals on erythrocyte-modifying, antigenic, toxic and pyrogenic properties. J Immunol (1956) 7.13
Structure and antigenicity of the phosphorylated lipopolysaccharide antigens from the leprosy and tubercle bacilli. J Biol Chem (1986) 4.52
Definition of species specific and cross-reactive antigenic determinants of Mycobacterium leprae using monoclonal antibodies. Clin Exp Immunol (1983) 3.85
Immunological activity of a 38-kilodalton protein purified from Mycobacterium tuberculosis. Infect Immun (1986) 3.44
Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc Natl Acad Sci U S A (1988) 3.04
The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. Immunology (1987) 2.91
T lymphocytes respond to solid-phase antigen: a novel approach to the molecular analysis of cellular immunity. Immunology (1986) 2.45
Malarial parasites induce TNF production by macrophages. Immunology (1988) 2.42
Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages. Infect Immun (1988) 2.21
Lipoarabinomannan and lipid-free arabinomannan antigens of Mycobacterium paratuberculosis. Infect Immun (1987) 1.93
Non-reactive tuberculosis. J Clin Pathol (1954) 1.85
Action of recombinant human interleukin 6, interleukin 1 beta and tumor necrosis factor alpha on the mRNA induction of acute-phase proteins. Eur J Immunol (1988) 1.76
Role of activated macrophages in the immunopathology of tuberculosis. Br Med Bull (1988) 1.75
The inhibitory effects of mycobacterial lipoarabinomannan and polysaccharides upon polyclonal and monoclonal human T cell proliferation. Clin Exp Immunol (1988) 1.75
Most Mycobacterium leprae carbohydrate-reactive monoclonal antibodies are directed to lipoarabinomannan. Infect Immun (1987) 1.73
Preparation and characterization of monoclonal antibodies directed against antigenic determinants of recombinant human tumour necrosis factor (rTNF). Hybridoma (1987) 1.68
Leprosy and the leprosy bacillus: recent developments in characterization of antigens and immunology of the disease. Annu Rev Microbiol (1987) 1.36
Demonstration of soluble Plasmodium falciparum antigens reactive with Limulus amoebocyte lysate and polymyxin B. Parasite Immunol (1988) 1.10
Mechanism of the anti-tumour effect of glucans and fructosans: a comparison with C. parvum. Br J Cancer (1977) 0.91
The cellular basis of immunological responses. A synthesis of some current views. Lancet (1969) 6.05
Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology (1986) 3.98
Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet (2001) 3.71
A simple new method for using antigens separated by polyacrylamide gel electrophoresis to stimulate lymphocytes in vitro after converting bands cut from Western blots into antigen-bearing particles. J Immunol Methods (1987) 3.56
Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG. Infect Immun (1988) 3.35
Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology (1986) 3.33
Focal antibody production by transferred spleen cells in irradiated mice. Science (1965) 3.12
Strain differences in the immune response of mice. I. The neonatal response to sheep red cells. Immunology (1968) 2.98
The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. Immunology (1987) 2.91
Interactions of TRIC agents with macrophages and BHK-21 cells observed by electron microscopy. J Hyg (Lond) (1973) 2.85
I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages. Clin Exp Immunol (1985) 2.73
Cultivation of TRIC agents: a comparison between the use of BHK-21 and irradiated McCoy cells. J Hyg (Lond) (1974) 2.66
Mycobacterium tuberculosis DNA in tissue affected by sarcoidosis. BMJ (1993) 2.58
Immunosuppression in murine malaria. I. General characteristics. Clin Exp Immunol (1971) 2.56
Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet (1989) 2.43
Malarial parasites induce TNF production by macrophages. Immunology (1988) 2.42
A simple method for the solubilisation of reduced NBT, and its use as a colorimetric assay for activation of human macrophages by gamma-interferon. J Immunol Methods (1985) 2.38
The secreted antigens of Mycobacterium tuberculosis and their relationship to those recognized by the available antibodies. J Gen Microbiol (1988) 2.38
Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue. J Clin Invest (1991) 2.37
How environmental mycobacteria may predetermine the protective efficacy of BCG. Tubercle (1981) 2.34
Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum. Clin Exp Immunol (1984) 2.34
Endotoxin-induced serum factor kills malarial parasites in vitro. Infect Immun (1981) 2.30
Stress proteins may provide a link between the immune response to infection and autoimmunity. Int Immunol (1989) 2.21
Induction of red cell autoantibodies in normal mice. Nat New Biol (1973) 2.09
Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis. J Infect Dis (2000) 2.08
The role of TNF-alpha in T-cell-mediated inflammation depends on the Th1/Th2 cytokine balance. Immunology (1994) 2.08
Cellular immune response to common mycobacterial antigens in subjects seropositive for Trypanosoma cruzi. Lancet (1994) 2.06
Malaria: phosphatidylserine expression is not increased on the surface of parasitized erythrocytes. Parasitol Today (1995) 2.05
Protection of mice against malaria by a killed vaccine: differences in effectiveness against P. yoelii and P. berghei. Immunology (1977) 2.03
Immunosuppressive potency and in-vitro activity of antilymphocyte globulin. Lancet (1969) 2.02
Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production. J Clin Invest (1989) 2.01
Characterization of T cell antigens associated with the cell wall protein-peptidoglycan complex of Mycobacterium tuberculosis. J Immunol (1989) 2.01
Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon. Clin Exp Immunol (1988) 1.92
Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet (1987) 1.91
Cell cooperation in the immune response. Clin Exp Immunol (1971) 1.91
Smoking and tuberculosis: the epidemiological association and immunopathogenesis. Trans R Soc Trop Med Hyg (2005) 1.88
Raised serum IgG and IgA antibodies to mycobacterial antigens in rheumatoid arthritis. Ann Rheum Dis (1989) 1.85
Cytokine inter-relationships and their association with disease activity in arthritis. Br J Rheumatol (1992) 1.85
Preliminary taxonomic studies on the leprosy bacillus. Br J Exp Pathol (1975) 1.83
Cell-mediated immunity in mice vaccinated against malaria. Clin Exp Immunol (1978) 1.82
Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet (1988) 1.82
Differential sensitivity in vivo of lethal and nonlethal malarial parasites to endotoxin-induced serum factor. Infect Immun (1982) 1.79
Suppressor T cells in experimental autoimmune haemolytic anaemia. Nature (1978) 1.79
Separate thymus dependent and thymus independent antibody forming cell precursors. Nat New Biol (1971) 1.78
Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid. Immunology (1992) 1.78
Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo. Immunology (1989) 1.77
Killing of human malaria parasites by macrophage secretory products. Infect Immun (1984) 1.76
Role of activated macrophages in the immunopathology of tuberculosis. Br Med Bull (1988) 1.75
Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria. Infect Immun (1997) 1.75
The inhibitory effects of mycobacterial lipoarabinomannan and polysaccharides upon polyclonal and monoclonal human T cell proliferation. Clin Exp Immunol (1988) 1.75
Killing of blood-stage murine malaria parasites by hydrogen peroxide. Infect Immun (1983) 1.74
The malaria vaccine: anti-parasite or anti-disease? Immunol Today (1990) 1.74
Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. EMBO J (2000) 1.71
Association of innate immune activation with latent Epstein-Barr virus in active MS lesions. Neurology (2011) 1.70
Genetic and immunological analysis of Mycobacterium tuberculosis fibronectin-binding proteins. Infect Immun (1991) 1.69
Dengue virus-specific human T cell clones. Serotype crossreactive proliferation, interferon gamma production, and cytotoxic activity. J Exp Med (1989) 1.68
Preparation and characterization of monoclonal antibodies directed against antigenic determinants of recombinant human tumour necrosis factor (rTNF). Hybridoma (1987) 1.68
The role of antibody in T-cell responses. Clin Exp Immunol (1974) 1.67
Antitumor activity of the novel human breast cancer growth inhibitor, mammary-derived growth inhibitor-related gene, MRG. Cancer Res (1997) 1.66
Lipopolysaccharide, tumor necrosis factor, and interleukin-1 interact to cause hypotension. J Lab Clin Med (1992) 1.65
The role of the liver in immunity to blood-stage murine malaria. Immunology (1980) 1.65
Immune interferon produced to high levels by antigenic stimulation of human lymphocytes with influenza virus. J Exp Med (1981) 1.64
Cell-mediated immunity in the liver of mice vaccinated against malaria. Nature (1979) 1.64
Strain differences in the behavior of TRIC agnets in cell cultures. Am J Ophthalmol (1967) 1.62
Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro. Clin Exp Immunol (1987) 1.62
Rosette formation by mouse lymphocytes. III. Receptors for immunoglobulin on normal and activated T cells. Clin Exp Immunol (1974) 1.59
Specific detection of Mycobacterium paratuberculosis DNA associated with granulomatous tissue in Crohn's disease. Gut (1994) 1.57
Strain differences in the immune responses of mice. 3. A raised tolerance threshold in NZB thymus cells. Immunology (1971) 1.57
Structure of the glycosyl-phosphatidylinositol membrane anchor of the Leishmania major promastigote surface protease. J Biol Chem (1990) 1.56
Attachment of mycobacteria to fibronectin-coated surfaces. J Gen Microbiol (1988) 1.56
High levels of interferon alpha in the sera of children with dengue virus infection. Am J Trop Med Hyg (1993) 1.56
An inhibitor of the toxicity of tumour necrosis factor in the serum of patients with sarcoidosis, tuberculosis and Crohn's disease. Clin Exp Immunol (1990) 1.53
Antibody levels to mycobacteria in relation to HLA type: evidence for non-HLA-linked high levels of antibody to the 65 kD heat shock protein of M. bovis in rheumatoid arthritis. Clin Exp Immunol (1988) 1.53
Specific tolerance to sheep erythrocytes in mouse bone marrow cells. Nature (1969) 1.52
Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown. Cancer Res (1990) 1.51
Elevated IgG antibody levels to the mycobacterial 65-kDa heat shock protein are characteristic of patients with rheumatoid arthritis. Scand J Immunol (1989) 1.49
Autoimmune reactions to heat-shock proteins in pristane-induced arthritis. Eur J Immunol (1990) 1.48
Expression and rescuing of a cloned human tumour necrosis factor gene using an EBV-based shuttle cosmid vector. EMBO J (1987) 1.48
Response of mouse T and B lymphocytes to sheep erythrocytes. Nat New Biol (1972) 1.45
Strain differences in the immune response of mice. II. Responses by neonatal cells in irradiated adult hosts. Immunology (1968) 1.45
Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae. Immunology (1998) 1.44
Interactions of TRIC agents with macrophages: effects on lysosomal enzymes of the cell. J Hyg (Lond) (1974) 1.43
Recombinant gamma interferon is a potent adjuvant for a malaria vaccine in mice. Clin Exp Immunol (1987) 1.42